The bile acid receptor TGR5 inhibits platelet activation and thrombus formation

References

• Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007;100(12):1673–13. doi:10.1161/01.RES.0000267878.97021.ab.
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate–receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657–666. doi:10.1016/S0092-8674(00)81607-4.
   PubMed Web of Science ®Google Scholar
• Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37(2):280–287. doi:10.1016/S0168-8278(02)00199-X.
   PubMed Web of Science ®Google Scholar
• Lisman T, Porte RJ. Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost. 2010;36(4):437–443. doi:10.1055/s-0030-1254052.
   Web of Science ®Google Scholar
• Ben-Ari Z, Osman E, Hutton RA, Burroughs AK. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol. 1999;94(10):2977–82. doi:10.1111/j.1572-0241.1999.01446.x.
   Web of Science ®Google Scholar
• Carr JM. Disseminated intravascular coagulation in cirrhosis. Hepatology. 1989;10(1):103–10. doi:10.1002/hep.1840100120.
   Web of Science ®Google Scholar
• Stein SF, Harker LA. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med. 1982;99:217–30.
   PubMed Web of Science ®Google Scholar
• Baele G, Beke R, Barbier F. In vitro inhibition of platelet aggregation by bile salts. Thromb Haemost. 1980;44(2):62–4. doi:10.1055/s-0038-1650084.
   Web of Science ®Google Scholar
• Takano S, Suzuki T. Effect of bile on aggregation and morphology of rabbit platelets. Tohoku J Exp Med. 1980;131(1):71–8. doi:10.1620/tjem.131.71.
   Web of Science ®Google Scholar
• Pereira J, Accatino L, Pizarro M, Mezzano V, Ibañez A, Mezzano D. In vivo effect of bile salts on platelet aggregation in rats. Thromb Res. 1995;80(4):357–62. doi:10.1016/0049-3848(95)00187-V.
   Web of Science ®Google Scholar
• Tag CG, Sauer-Lehnen S, Weiskirchen S, Borkham-Kamphorst E, Tolba RH, Tacke F, Weiskirchen R. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp. 2015;(96). doi:10.3791/52438-v.
   Web of Science ®Google Scholar
• Gowert NS, Klier M, Reich M, Reusswig F, Donner L, Keitel V, Häussinger D, Elvers M. Defective platelet activation and bleeding complications upon cholestasis in mice. Cell Physiol Biochem. 2017;41(6):2133–49. doi:10.1159/000475566.
   PubMedGoogle Scholar
• Walter U, Eigenthaler M, Geiger J, Reinhard M. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol. 1993;344:237–49.
   PubMedGoogle Scholar
• Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev. 2021;101(2):683–731. doi:10.1152/physrev.00049.2019.
   PubMed Web of Science ®Google Scholar
• Moraes LA, Unsworth AJ, Vaiyapuri S, Ali MS, Sasikumar P, Sage T, Flora GD, Bye AP, Kriek N, Dorchies E, et al. Farnesoid X receptor and its ligands inhibit the function of platelets. Arterioscler Thromb Vasc Biol. 2016;36(12):2324–2333. doi:10.1161/ATVBAHA.116.308093.
   Web of Science ®Google Scholar
• Keitel V, Häussinger D. Role of TGR5 (GPBAR1) in liver disease. Semin Liver Dis. 2018;38(4):333–339. doi:10.1055/s-0038-1669940.
   PubMed Web of Science ®Google Scholar
• Keitel V, Häussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol. 2012;36(5):412–9. doi:10.1016/j.clinre.2012.03.008.
   PubMed Web of Science ®Google Scholar
• Reich M, Deutschmann K, Sommerfeld A, Klindt C, Kluge S, Kubitz R, Ullmer C, Knoefel WT, Herebian D, Mayatepek E, et al. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut. 2016;65(3):487–501. doi:10.1136/gutjnl-2015-309458.
   PubMed Web of Science ®Google Scholar
• Keitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, Häussinger D. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology. 2009;50(3):861–70. doi:10.1002/hep.23032.
   PubMed Web of Science ®Google Scholar
• Reusswig F, Fazel Modares N, Brechtenkamp M, Wienands L, Krüger I, Behnke K, Lee‐Sundlov MM, Herebian D, Scheller J, Hoffmeister KM, et al. Efficiently restored thrombopoietin production by Ashwell-Morell receptor and IL-6R induced Janus Kinase 2/Signal transducer and activator of transcription signaling early after partial hepatectomy. Hepatology. 2021;74(1):411–427. doi:10.1002/hep.31698.
   Web of Science ®Google Scholar
• Deutschmann K, Reich M, Klindt C, Dröge C, Spomer L, Häussinger D, Keitel V. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4):1319–25. doi:10.1016/j.bbadis.2017.08.021.
   PubMed Web of Science ®Google Scholar
• Kida T, Tsubosaka Y, Hori M, Ozaki H, Murata T. Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(7):1663–9. doi:10.1161/ATVBAHA.113.301565.
   PubMed Web of Science ®Google Scholar
• Nagy Z, Smolenski A. Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses. Res Pract Thromb Haemost. 2018;2(3):558–71. doi:10.1002/rth2.12122.
   Web of Science ®Google Scholar
• Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke. 2003;34(3):764–769. doi:10.1161/01.STR.0000056527.34434.59PMID:12624305.
   Google Scholar
• Laffi G, Cominelli F, Ruggiero M, Fedi S, Chiarugi VP, La Villa G, Pinzani M, Gentilini P. Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists. Hepatology. 1988;8(6):1620–6. doi:10.1002/hep.1840080625.
   PubMed Web of Science ®Google Scholar
• Ordinas A, Escolar G, Cirera I, Vinas M, Cobo F, Bosch J, Teres J, Rodés J. Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology. 1996;24(5):1137–42. doi:10.1002/hep.510240526.
   PubMed Web of Science ®Google Scholar
• Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG, et al. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology. 1992;103(2):641–6. doi:10.1016/0016-5085(92)90859-W.
   PubMed Web of Science ®Google Scholar
• Owen JS, Hutton RA, Day RC, Bruckdorfer KR, McIntyre N. Platelet lipid composition and platelet aggregation in human liver disease. J Lipid Res. 1981;22(3):423–30. doi:10.1016/S0022-2275(20)34955-5.
   Web of Science ®Google Scholar
• Albornoz L, Bandi JC, Otaso JC, Laudanno O, Mastai R. Prolonged bleeding time in experimental cirrhosis: role of nitric oxide. J Hepatol. 1999;30(3):456–60. doi:10.1016/S0168-8278(99)80105-6.
   Web of Science ®Google Scholar
• Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, Gentilini P. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology. 1993;105(1):148–56. doi:10.1016/0016-5085(93)90020-D.
   Web of Science ®Google Scholar
• Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, et al. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol. 2006;12(10):1607–12. doi:10.3748/wjg.v12.i10.1607.
   PubMed Web of Science ®Google Scholar
• Ingeberg S, Jacobsen P, Fischer E, Bentsen KD. Platelet aggregation and release of ATP in patients with hepatic cirrhosis. Scand J Gastroenterol. 1985;20(3):285–8. doi:10.3109/00365528509091651.
   PubMed Web of Science ®Google Scholar
• Pihusch R, Salat C, Göhring P, Hentrich M, Wegner H, Pihusch M, Hiller E, Kolb H-J, Ostermann H. Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut. Br J Haematol. 2002;117(2):469–76. doi:10.1046/j.1365-2141.2002.03420.x.
   Web of Science ®Google Scholar
• Atucha NM, Iyú D, Alcaraz A, Rosa V, Martínez-Prieto C, Ortiz M, Rosado J, García-Estañ J. Altered calcium signalling in platelets from bile-duct-ligated rats. Clin Sci (Lond). 2007;112(3):167–74. doi:10.1042/CS20060226.
   Web of Science ®Google Scholar
• Chirkov YY, Nguyen TH, Horowitz JD. Impairment of anti-aggregatory responses to nitric oxide and prostacyclin: mechanisms and clinical implications in cardiovascular disease. Int J Mol Sci. 2022;23(3):1042. doi:10.3390/ijms23031042.
   PubMed Web of Science ®Google Scholar